Organoids and Spheroids Market Size Worth $ 13.99 billion by 2034 | CAGR: 23.3%
The global organoids and spheroids market size is expected to reach USD 13.99 billion by 2034, according to a new study by Polaris Market Research. The report “Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report – By Type, Application, End Use, and Region; Segment Forecasts, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The development of genetic editing techniques such as CRISPR/Cas-9 has enabled researchers to make precise changes to genes in stem cells, leading to the creation of organoids and spheroids that replicate disease conditions. These advancements have provided researchers with improved models for studying diseases and testing drugs, yielding valuable insights into complex cellular conditions. The combination of progress in stem cell technology and 3D culture methods has played a crucial role in the steady growth of the organoids and spheroids market. In January 2024, USC researchers developed a new human brain organoid model to study cerebellum development and the emergence of cerebellar pathology in neurological disease.
Patient-specific organoids represent a robust platform for advancing personalized medicine and driving the growth of the organoids and spheroids market by enabling the testing of potential drugs on tissues sourced from patients, which provides valuable insights into individual therapy responses. The clinical importance of organoids and spheroids in both research and clinical practice is crucial for developing personalized organoid models and furthering the progress of P4 medicine.
The development of 3D bioprinting technologies and organ-on-a-chip platforms significantly advances organoid and spheroid research. 3D bioprinting enables the creation of complex, customized tissue models with high precision, enhancing drug testing and personalized medicine. Organ-on-a-chip platforms replicate organ functions in miniature, allowing for dynamic modeling, high-throughput screening, and personalized treatment strategies. Together, these innovations improve the accuracy and relevance of biomedical research, facilitating more effective drug development and disease understanding.
Organoids and Spheroids Market Report Highlights
- Based on type, the spheroids segment held a larger share in 2025, owing to their significant use in drug discovery and disease modeling.
- The organoids segment is projected to grow rapidly during the forecast period, fueled by rising occurrences of diseases such as cancer, neurodegenerative disorders, and infectious diseases, driving demand for advanced research models.
- By application, the developmental biology segment dominated the market in 2025, owing to its application in the mechanism of organogenesis.
- North America holds the largest share in 2025, owing to the rising use of organoids and spheroids for personalized medicine.
- A few key players are 3D Biomatrix, 3D Biotek, AMS Biotechnology, Cellesce, Greiner Bio-One, and Thermo Fisher Scientific.
Request a free sample copy or read the full market insights: Organoids and Spheroids Market Report
Polaris Market Research has segmented the organoids and spheroids market report on the basis of type, application, end use, and region:
By Type Outlook (Revenue – USD billion, 2021–2034)
- Organoids
- By Type
- Neural Organoids
- Hepatic Organoids
- Intestinal Organoids
- Other Organoids
- By Method
- General Submerged Method for Organoid Culture
- Crypt Organoid Culture Techniques
- Air Liquid Interface (ALI) Method for Organoid Culture
- Clonal Organoids from Lgr5+ Cells
- Brain and Retina Organoid Formation Protocol
- Others
- By Source
- Primary Tissues
- Stem Cells
- By Type
- Spheroids
- By Type
- Multicellular Tumor Spheroids (MCTS)
- Neurospheres
- Mammospheres
- Hepatospheres
- Embryoid Bodies
- By Method
- Micropatterned Plates
- Low Cell Attachment Plates
- Hanging Drop Method
- Others
- By Source
- Cell Line
- Primary Cell
- iPSCs Derived Cells
- By Type
By Application Outlook (Revenue – USD billion, 2021–2034)
- Developmental Biology
- Personalized Medicine
- Regenerative Medicine
- Disease Pathology Studies
- Drug Toxicity & Efficacy Testing
By End Use Outlook (Revenue – USD billion, 2021–2034)
- Biotechnology & Pharmaceutical Industries
- Academic & Research Institutes
- Hospitals & Diagnostic Centers
By Regional Outlook (Revenue – USD billion, 2021–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Organoids and Spheroids Market Report Scope
|
Report Attributes |
Details |
|
Market Size Value in 2025 |
USD 2.14 billion |
|
Revenue Forecast by 2034 |
USD 13.99 billion |
|
CAGR |
23.3% from 2026 to 2034 |
|
Base Year |
2025 |
|
Historical Data |
2021–2024 |
|
Forecast Period |
2026–2034 |
|
Quantitative Units |
Revenue in USD billion and CAGR from 2026 to 2034 |
|
Segments Covered |
|
|
Regional Scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
|
For Specific Research Requirements |
